Form 4: Surgery Partners Director Acquires Shares Under Pre-Arranged 10b5-1 Plan

Surgery Partners, Inc. Director John A. Deane acquired 6,861 shares of common stock at $23.32 per share on June 10, 2025, under a Rule 10b5-1 trading plan.

Summary

• John A. Deane, a Director of Surgery Partners, Inc. (SGRY), acquired 6,861 shares of the company's common stock.
• The transaction occurred on June 10, 2025, at a price of $23.32 per share.
• Following this acquisition, Mr. Deane beneficially owns a total of 34,252 shares of Surgery Partners common stock.
• The acquired shares are scheduled to vest on June 10, 2026.
• This transaction was executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase of equity securities.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as a director's acquisition of shares, even under a pre-planned arrangement, generally signals confidence in the company's future. However, it's a routine disclosure and not indicative of a major strategic shift or immediate financial performance.

Positives

• The acquisition of shares by a director can signal confidence in the company's future prospects and valuation.
• The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled and transparent acquisition strategy.

Future Outlook

The acquired shares are subject to a vesting period, with full vesting expected on June 10, 2026, indicating a future milestone for the newly acquired equity.

Industry Context

Insider transactions, particularly acquisitions by directors, are common in the healthcare services industry and are often viewed by investors as an indicator of management's belief in the company's long-term value. Transactions executed under Rule 10b5-1 plans are pre-scheduled and are a standard practice for insiders to manage their equity holdings in compliance with insider trading regulations.

Stakeholder Impact

• Shareholders may interpret the director's share acquisition as a positive signal regarding the company's future prospects and management's alignment with shareholder interests.

Next Steps

• The 6,861 shares acquired by John A. Deane are expected to vest on June 10, 2026.

Key Dates

Keywords

Surgery Partners, SGRY, Form 4, insider transaction, stock acquisition, director, equity ownership, 10b5-1 plan, beneficial ownership